Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
73,01 INR | +2,61% | +3,34% | -6,80% |
Attività
Numero di dipendenti: 210
Vendite per attività
INR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Active Pharmaceutical Ingredients
100,0
%
| 529 | 100,0 % | 521 | 100,0 % | -1,52% |
Vendite per regione
INR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
India
100,0
%
| 529 | 100,0 % | 521 | 100,0 % | -1,52% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Jitendra Shah
CEO | Chief Executive Officer | - | 09/11/21 |
Founder | 74 | 02/12/91 | |
Ritesh Jain
DFI | Director of Finance/CFO | - | 03/02/23 |
Director/Board Member | 55 | - | |
Avinash Ravi
BRD | Director/Board Member | 45 | 01/01/02 |
Sudhir Manne
PRN | Corporate Officer/Principal | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 67 | 26/09/00 | |
Founder | 74 | 02/12/91 | |
Avinash Ravi
BRD | Director/Board Member | 45 | 01/01/02 |
Director/Board Member | 75 | 12/02/16 | |
Malati Tangirala
BRD | Director/Board Member | 74 | 01/01/14 |
Director/Board Member | 78 | 29/09/15 | |
Director/Board Member | 55 | - | |
Jitendra Shah
CEO | Chief Executive Officer | - | 09/11/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 21 560 000 | 4 839 509 ( 22,45 %) | 0 | 22,45 % |
Coordinate società
Krebs Biochemicals & Industries Ltd.
Plot No.34, 8-2-577/B 3rd Floor, Maas Heights
500034, Hyderabad
+
http://krebsbiochem.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
-6,80% | 18,88 Mln | |
+19,62% | 43,34 Mrd | |
+20,44% | 21,96 Mrd | |
+10,86% | 14,09 Mrd | |
+13,07% | 13,64 Mrd | |
+37,46% | 11,43 Mrd | |
-8,59% | 6,86 Mrd | |
-0,05% | 6,79 Mrd | |
-8,87% | 5,73 Mrd | |
+8,46% | 5,22 Mrd |
- Borsa valori
- Azioni
- Azione KREBSBIO
- Società Krebs Biochemicals & Industries Limited